Vertice Pharma closes VistaPharm buy
Vertice Pharma said Tuesday it closed its previously announced acquisition of VistaPharm. Financial terms weren’t announced. Warburg Pincus is investing up to $300 million.
23 December 2015•2 mins read
Vertice Pharma said Tuesday it closed its previously announced acquisition of VistaPharm. Financial terms weren’t announced. Warburg Pincus is investing up to $300 million.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
6 November 2026 · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
6 November 2026 · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
6 November 2026 · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
6 November 2026 · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
6 November 2026 · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
6 November 2026 · 1 min read
PE targets identity security as AI transforms threats: 6 deals
6 November 2026 · 3 mins read
